Tauvid™: The First FDA-Approved PET Tracer for Imaging Tau Pathology in Alzheimer's Disease

• 主要な著者: Caitlin V. M. L. Jie (著者), Valerie Treyer (著者), Roger Schibli (著者), Linjing Mu (著者)
• フォーマット: 図書
• 出版事項: MDPI AG, 2021-01-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Tauvid has been approved by the U.S. Food and Drug Administration (FDA) in 2020 for positron emission tomography (PET) imaging of adult patients with cognitive impairments undergoing evaluation for Alzheimer's disease (AD) based on tau pathology. Abnormal aggregation of tau proteins is one of t...